Pay in 4 interest-free payments of $7.49 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
Virtual-care platforms evaluate eligible patients for GLP-1 treatment and coordinate the clinical, behavioral and pharmacy steps needed for remote obesity or metabolic care
The SURMOUNT trials showed tirzepatide producing average weight loss of 20 to 22.5 percent at the highest dose over 72 weeks, compared to semaglutide 14.9 percent in STEP 1
Common side effectsnausea, vomiting, constipation, diarrheaoccur in 2040% of patients during dose escalation and typically resolve within days to weeks as the body adapts
The purified tirzepatideGLP-1RG s Nb35 complex (3 L at about 20 mg/mL) was applied to a glow-discharged holey carbon grid (Quantifoil R1.2/1.3) and blotted subsequently
Check the product's storage instructions, and if they recommend refrigeration, ensure you can accommodate this requirement
